Insider Transactions Reported by 21 Insiders of KalVista Pharmaceuticals, Inc.

Symbol
KALV on Nasdaq
Location
Framingham, MA

Insiders trading volume in the past year

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners III, L.P. 10%+ Owner $49,963,539 +$235,500 +0.47% 09 Apr 2025
Benjamin L. Palleiko CHIEF EXECUTIVE OFFICER, Director $9,144,577 -$1,806,389 -16% 06 Mar 2026
Thomas Andrew Crockett CEO, Director $4,648,801 17 Feb 2024
Christopher Yea Chief Development Officer $3,928,117 -$828,582 -17% 21 Feb 2026
Paul K. Audhya Chief Medical Officer $3,816,820 -$414,638 -9.8% 21 Feb 2026
Edward P. Feener Chief Scientific Officer $1,200,262 17 May 2024
Brian Piekos Chief Financial Officer $1,000,166 -$87,646 -8.1% 21 Feb 2026
Nicole Sweeny Chief Commercial Officer $731,686 -$157,676 -18% 21 Feb 2026
Michael David Smith Senior VP, Development $127,390 17 May 2022
Albert Cha Director 26 Sep 2023
Patrick Treanor Director 01 Oct 2025
Brian JG Pereira Director 01 Oct 2025
Nancy Stuart Director 01 Oct 2025
DANIEL B. SOLAND Director 30 Sep 2021
Edward W. Unkart Director 01 Oct 2025
Bethany Sensenig Director 01 Oct 2025
Bilal Arif Chief Operations Officer 16 Jan 2026
Laurence Reid Director 23 Nov 2024
Andreas Maetzel Senior Vice President, Medical 26 May 2021
William Fairey Director 01 Oct 2025
Martin Edwards Director 30 Sep 2021

Recent Insider Transactions by Companies or Individuals for KalVista Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Benjamin L. Palleiko KALV Common Stock Sale -1.46% $107,633 $16.08 -6,693 451,815 09 Mar 2026 Direct
Benjamin L. Palleiko KALV Common Stock Options Exercise 3.53% 15,625 458,508 06 Mar 2026 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Options Exercise -11.1% -15,625 125,001 06 Mar 2026 Direct
Paul K. Audhya KALV Common Stock Sale -3.71% $83,345 $15.57 -5,354 138,983 23 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Sale -2.22% $156,197 $15.57 -10,034 442,883 23 Feb 2026 Direct
Christopher Yea KALV Common Stock Sale -1.88% $67,669 $15.57 -4,347 226,701 23 Feb 2026 Direct
Nicole Sweeny KALV Common Stock Sale -7.8% $61,878 $15.57 -3,975 47,003 23 Feb 2026 Direct
Brian Piekos KALV Common Stock Sale -11.4% $27,507 $15.57 -1,767 13,762 23 Feb 2026 Direct
Paul K. Audhya KALV Common Stock Options Exercise 3.59% 5,000 144,337 22 Feb 2026 Direct
Paul K. Audhya KALV Restricted Stock Unit Options Exercise -10% -5,000 45,000 22 Feb 2026 Direct
Christopher Yea KALV Common Stock Options Exercise 1.37% 3,125 231,048 22 Feb 2026 Direct
Christopher Yea KALV Restricted Stock Unit Options Exercise -10% -3,125 28,125 22 Feb 2026 Direct
Nicole Sweeny KALV Common Stock Options Exercise 10.9% 5,000 50,978 22 Feb 2026 Direct
Nicole Sweeny KALV Restricted Stock Unit Options Exercise -10% -5,000 45,000 22 Feb 2026 Direct
Paul K. Audhya KALV Common Stock Options Exercise 4.7% 6,250 139,337 21 Feb 2026 Direct
Paul K. Audhya KALV Restricted Stock Unit Options Exercise -7.69% -6,250 75,000 21 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Options Exercise 5.41% 23,250 452,917 21 Feb 2026 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Options Exercise -7.69% -23,250 279,000 21 Feb 2026 Direct
Christopher Yea KALV Common Stock Options Exercise 1.67% 3,750 227,923 21 Feb 2026 Direct
Christopher Yea KALV Restricted Stock Unit Options Exercise -7.69% -3,750 45,000 21 Feb 2026 Direct
Nicole Sweeny KALV Common Stock Options Exercise 15.7% 6,250 45,978 21 Feb 2026 Direct
Nicole Sweeny KALV Restricted Stock Unit Options Exercise -7.69% -6,250 75,000 21 Feb 2026 Direct
Brian Piekos KALV Common Stock Options Exercise 47.5% 5,000 15,529 21 Feb 2026 Direct
Brian Piekos KALV Restricted Stock Unit Options Exercise -7.69% -5,000 60,000 21 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Sale -0.24% $15,570 $15.00 -1,038 429,667 18 Feb 2026 Direct
Paul K. Audhya KALV Common Stock Sale -0.87% $17,445 $15.00 -1,163 133,087 18 Feb 2026 Direct
Christopher Yea KALV Common Stock Sale -0.49% $16,635 $15.00 -1,109 224,173 18 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Options Exercise 0.56% 2,419 430,705 17 Feb 2026 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Options Exercise -50% -2,419 2,419 17 Feb 2026 Direct
Paul K. Audhya KALV Common Stock Options Exercise 1.83% 2,419 134,250 17 Feb 2026 Direct
Paul K. Audhya KALV Restricted Stock Unit Options Exercise -50% -2,419 2,419 17 Feb 2026 Direct
Christopher Yea KALV Common Stock Options Exercise 0.79% 1,774 225,282 17 Feb 2026 Direct
Christopher Yea KALV Restricted Stock Unit Options Exercise -50% -1,774 1,774 17 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Sale -0.78% $52,658 $15.70 -3,354 428,286 12 Feb 2026 Direct
Benjamin L. Palleiko KALV Common Stock Options Exercise 1.68% 7,120 431,640 11 Feb 2026 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Options Exercise -6.67% -7,120 99,680 11 Feb 2026 Direct
Bilal Arif KALV Restricted Stock Unit Award 49,000 49,000 16 Jan 2026 Direct
Nicole Sweeny KALV Restricted Stock Unit Award 100,000 100,000 16 Jan 2026 Direct
Brian Piekos KALV Restricted Stock Unit Award 100,000 100,000 16 Jan 2026 Direct
Paul K. Audhya KALV Restricted Stock Unit Award 100,000 100,000 16 Jan 2026 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Award 325,000 325,000 16 Jan 2026 Direct
Benjamin L. Palleiko KALV Common Stock Sale -1.69% $120,424 $16.51 -7,294 424,520 08 Dec 2025 Direct
Benjamin L. Palleiko KALV Common Stock Options Exercise 3.75% 15,625 431,814 06 Dec 2025 Direct
Benjamin L. Palleiko KALV Restricted Stock Unit Options Exercise -10% -15,625 140,626 06 Dec 2025 Direct
Nicole Sweeny KALV Common Stock Sale -8.76% $51,289 $13.45 -3,813 39,728 24 Nov 2025 Direct
Brian Piekos KALV Common Stock Sale -29.8% $60,139 $13.45 -4,471 10,529 24 Nov 2025 Direct
Christopher Yea KALV Common Stock Sale -1.9% $58,256 $13.45 -4,331 223,508 24 Nov 2025 Direct
Paul K. Audhya KALV Common Stock Sale -3.86% $71,236 $13.45 -5,296 131,831 24 Nov 2025 Direct
Benjamin L. Palleiko KALV Common Stock Sale -2.56% $147,154 $13.45 -10,940 416,189 24 Nov 2025 Direct
Nicole Sweeny KALV Common Stock Options Exercise 13% 5,000 43,541 22 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.